Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Alper

Showing results (81-90 of 310) with videos related to

Pageof 31
Sort By:
Folia Primatologica; International Journal of Primatology|January 1, 1975
Protein polymorphism in the Hanuman langur (Presbytis entellus)D B Hrdy, N A Barnicot, C A Alper
The Journal of Experimental Medicine|March 1, 1973
Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharideT P Stossel, C A Alper, F S Rosen
Pediatrics|July 1, 1973
Opsonic activity in the newborn: role of properdinT P Stossel, C A Alper, F S Rosen
Human Immunology|April 1, 1990
Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patientsA R Ahmed, E J Yunis, C A Alper
Complement and Inflammation|January 1, 1989
Complotypes and extended haplotypes in laboratory medicineC A Alper, Z L Awdeh, E J Yunis
Clinical Immunology and Immunopathology|April 1, 1991
Decreased inhibition of immune precipitation by sera with the C2 B allotypeL Varga, C A Alper, Z Zam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J Lachmann
Lancet (London, England)|June 9, 1979
Genetic marker for insulin-dependent diabetes mellitusD Raum, C A Alper, R Stein, et al.
Surgery|February 1, 1991
Antirejection effect of hepatotrophic factorsA Emre, T Altuğ, O Arioğul, et al.
Microvascular Research|February 28, 2020
Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysisA Alper Öztürk, İrem Namlı, Kadri Güleç, et al.
Pageof 31

Showing results (81-90 of 310) with videos related to

Sort By:
Pageof 31
Folia Primatologica; International Journal of Primatology|January 1, 1975
Protein polymorphism in the Hanuman langur (Presbytis entellus)D B Hrdy, N A Barnicot, C A Alper
The Journal of Experimental Medicine|March 1, 1973
Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharideT P Stossel, C A Alper, F S Rosen
Pediatrics|July 1, 1973
Opsonic activity in the newborn: role of properdinT P Stossel, C A Alper, F S Rosen
Human Immunology|April 1, 1990
Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patientsA R Ahmed, E J Yunis, C A Alper
Complement and Inflammation|January 1, 1989
Complotypes and extended haplotypes in laboratory medicineC A Alper, Z L Awdeh, E J Yunis
Clinical Immunology and Immunopathology|April 1, 1991
Decreased inhibition of immune precipitation by sera with the C2 B allotypeL Varga, C A Alper, Z Zam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J Lachmann
Lancet (London, England)|June 9, 1979
Genetic marker for insulin-dependent diabetes mellitusD Raum, C A Alper, R Stein, et al.
Surgery|February 1, 1991
Antirejection effect of hepatotrophic factorsA Emre, T Altuğ, O Arioğul, et al.
Microvascular Research|February 28, 2020
Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysisA Alper Öztürk, İrem Namlı, Kadri Güleç, et al.
Pageof 31